Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | coagulation factor II (thrombin) receptor | Starlite/ChEMBL | References |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | 0 uM | Ability of the compound to block collagen (3 ug/mL) induced platelet aggregation; inactive at a concentration of 50 microM | ChEMBL. | 12798334 |
IC50 (functional) | 0 uM | Ability of the compound to block U-46,619 (0.3 uM)-induced platelet aggregation; inactive at a concentration of 50 microM | ChEMBL. | 12798334 |
IC50 (functional) | = 0.16 uM | Ability to block TRAP-6 (2 uM)-induced platelet aggregation | ChEMBL. | 12798334 |
IC50 (functional) | = 0.34 uM | Ability to block thrombin (0.15 nM)-induced platelet aggregation | ChEMBL. | 12798334 |
IC50 (binding) | = 0.44 uM | Ability to inhibit the binding of [3H]-S-(p-F-Phe)-homoarginine-L-homoarginine-KY-NH2 to thrombin receptor on the membranes of CHRF-288-11 cells | ChEMBL. | 12798334 |
IC50 (binding) | = 0.44 uM | Ability to inhibit the binding of [3H]-S-(p-F-Phe)-homoarginine-L-homoarginine-KY-NH2 to thrombin receptor on the membranes of CHRF-288-11 cells | ChEMBL. | 12798334 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.